Prognostic enrichment for early-stage Huntington’s disease: An explainable machine learning approach for clinical trial

Ghofrani-Jahromi, Mohsen; Poudel, Govinda R.; Razi, Adeel; Abeyasinghe, Pubu M.; Paulsen, Jane S.; Tabrizi, Sarah J.; Saha, Susmita; Georgiou-Karistianis, Nellie

doi:10.1016/j.nicl.2024.103650

NeuroImage: Clinical

2024

DOI: 10.1016/j.nicl.2024.103650

|View full text |Cite

Prognostic enrichment for early-stage Huntington’s disease: An explainable machine learning approach for clinical trial

Mohsen Ghofrani-Jahromi,

Govinda R. Poudel,

Adeel Razi

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 78 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Machine learning‐based radiomics in neurodegenerative and cerebrovascular disease

Shi,

Feng,

Zhi

et al. 2024

MedComm

View full text Add to dashboard Cite

Cognitive impairments, which can be caused by neurodegenerative and cerebrovascular disease, represent a growing global health crisis with far‐reaching implications for individuals, families, healthcare systems, and economies worldwide. Notably, neurodegenerative‐induced cognitive impairment often presents a different pattern and severity compared to cerebrovascular‐induced cognitive impairment. With the development of computational technology, machine learning techniques have developed rapidly, which offers a powerful tool in radiomic analysis, allowing a more comprehensive model that can handle high‐dimensional, multivariate data compared to the traditional approach. Such models allow the prediction of the disease development, as well as accurately classify disease from overlapping symptoms, therefore facilitating clinical decision making. This review will focus on the application of machine learning‐based radiomics on cognitive impairment caused by neurogenerative and cerebrovascular disease. Within the neurodegenerative category, this review primarily focuses on Alzheimer's disease, while also covering other conditions such as Parkinson's disease, Lewy body dementia, and Huntington's disease. In the cerebrovascular category, we concentrate on poststroke cognitive impairment, including ischemic and hemorrhagic stroke, with additional attention given to small vessel disease and moyamoya disease. We also review the specific challenges and limitations when applying machine learning radiomics, and provide our suggestion to overcome those limitations towards the end, and discuss what could be done for future clinical use.

show abstract

Machine learning‐based radiomics in neurodegenerative and cerebrovascular disease

Shi,

Feng,

Zhi

et al. 2024

MedComm

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Prognostic enrichment for early-stage Huntington’s disease: An explainable machine learning approach for clinical trial

Cited by 1 publication

References 78 publications

Machine learning‐based radiomics in neurodegenerative and cerebrovascular disease

Machine learning‐based radiomics in neurodegenerative and cerebrovascular disease

Contact Info

Product

Resources

About